114 related articles for article (PubMed ID: 11038767)
21. Identification of H, K, and N-ras point mutations in stage IB cervical carcinoma.
Grendys EC; Barnes WA; Weitzel J; Sparkowski J; Schlegel R
Gynecol Oncol; 1997 May; 65(2):343-7. PubMed ID: 9159349
[TBL] [Abstract][Full Text] [Related]
22. An evaluation of the diagnostic and prognostic significance of p16(INK4a) /p21(WAF1/Cip1) immunostaining in squamous intraepithelial lesions of the uterine cervix using liquid-based cytology specimens.
Ishida K; Araki A; Kobayashi M; Taniyama K; Nabika T; Nagasaki M
Diagn Cytopathol; 2014 Feb; 42(2):125-33. PubMed ID: 23754829
[TBL] [Abstract][Full Text] [Related]
23. Analysis and clinical implications of K-ras gene mutations and infection with human papillomavirus types 16 and 18 in primary adenocarcinoma of the uterine cervix.
Tenti P; Romagnoli S; Silini E; Pellegata NS; Zappatore R; Spinillo A; Zara C; Ranzani GN; Carnevali L
Int J Cancer; 1995 Feb; 64(1):9-13. PubMed ID: 7665253
[TBL] [Abstract][Full Text] [Related]
24. A two-step enriched-nested PCR technique enhances sensitivity for detection of codon 12 K-ras mutations in pancreatic adenocarcinoma.
Banerjee SK; Makdisi WF; Weston AP; Campbell DR
Pancreas; 1997 Jul; 15(1):16-24. PubMed ID: 9211488
[TBL] [Abstract][Full Text] [Related]
25. Genetic alterations in the K-Ras gene influence the prognosis in patients with cervical cancer treated by radiotherapy.
Wegman P; Ahlin C; Sorbe B
Int J Gynecol Cancer; 2011 Jan; 21(1):86-91. PubMed ID: 21330833
[TBL] [Abstract][Full Text] [Related]
26. Ha-ras oncogene mutation associated to progression of papillomavirus induced lesions of uterine cervix.
Alonio LV; Picconi MA; Dalbert D; Mural J; Bartt O; Bazán G; Dominguez M; Teyssié AR
J Clin Virol; 2003 Aug; 27(3):263-9. PubMed ID: 12878090
[TBL] [Abstract][Full Text] [Related]
27. BAG3 expression correlates with the grade of dysplasia in squamous intraepithelial lesions of the uterine cervix.
Raffone A; Travaglino A; D'Antonio A; De Marco M; Caccese M; Mascolo M; Insabato L; Zeppa P; Rosati A; Mollo A; Zullo F; Guida M
Acta Obstet Gynecol Scand; 2020 Jan; 99(1):99-104. PubMed ID: 31444794
[TBL] [Abstract][Full Text] [Related]
28. Genetic damage in exfoliated cells of the uterine cervix. Association and interaction between cigarette smoking and progression to malignant transformation?
Cerqueira EM; Santoro CL; Donozo NF; Freitas BA; Pereira CA; Bevilacqua RG; Machado-Santelli GM
Acta Cytol; 1998; 42(3):639-49. PubMed ID: 9622681
[TBL] [Abstract][Full Text] [Related]
29. Differential activation of the c-Ki-ras-2 proto-oncogene in human colorectal carcinoma.
Halatsch ME; Hirsch-Ernst KI; Weinel RJ; Kahl GF
Anticancer Res; 1998; 18(4A):2323-5. PubMed ID: 9703874
[TBL] [Abstract][Full Text] [Related]
30. p53 and p21/Waf1 protein expression and K-ras codon 12 mutation in carcinoma of the papilla of Vater.
Zhao B; Kimura W; Futakawa N; Muto T; Kubota K; Harihara Y; Takayama T; Makuuchi M
Am J Gastroenterol; 1999 Aug; 94(8):2128-34. PubMed ID: 10445539
[TBL] [Abstract][Full Text] [Related]
31. Analysis of ras point mutations and human papillomavirus 16 and 18 in cervical carcinomata and their metastases.
Willis G; Jennings B; Ball RY; New NE; Gibson I
Gynecol Oncol; 1993 Jun; 49(3):359-64. PubMed ID: 8390962
[TBL] [Abstract][Full Text] [Related]
32. Ras p21 immunostaining in early stage squamous cervical carcinoma: relationship with lymph nodal involvement and 72 kDa-metalloproteinase index.
Garzetti GG; Ciavattini A; Lucarini G; Goteri G; Nictolis MD; Romanini C; Biagini G
Anticancer Res; 1998; 18(1B):609-13. PubMed ID: 9568185
[TBL] [Abstract][Full Text] [Related]
33. Clinicopathological significance of Ki-ras point mutation and p21 expression in benign and malignant exocrine tumors of the human pancreas.
Song MM; Nio Y; Sato Y; Tamura K; Furuse K
Int J Pancreatol; 1996 Oct; 20(2):85-93. PubMed ID: 8968863
[TBL] [Abstract][Full Text] [Related]
34. p53 status and human papillomavirus infection in Thai women with cervical carcinoma.
Limpaiboon T; Pooart J; Bhattarakosol P; Niruthisard S; Chantratita W; Lulitanond V
Southeast Asian J Trop Med Public Health; 2000 Mar; 31(1):66-71. PubMed ID: 11023067
[TBL] [Abstract][Full Text] [Related]
35. Expression of ras, c-myc, and p53 proteins in cervical intraepithelial neoplasia.
Marangoz S; Güllü IH
Cancer; 1999 Jun; 85(12):2668-9. PubMed ID: 10375117
[No Abstract] [Full Text] [Related]
36. K-ras activation in premalignant and malignant epithelial lesions of the human uterus.
Enomoto T; Inoue M; Perantoni AO; Buzard GS; Miki H; Tanizawa O; Rice JM
Cancer Res; 1991 Oct; 51(19):5308-14. PubMed ID: 1913654
[TBL] [Abstract][Full Text] [Related]
37. [Overexpression of p53 protein and its relation to HPV in squamous intraepithelial lesion and cervical carcinoma].
Li X; Mi R; Jiao S
Zhonghua Bing Li Xue Za Zhi; 1997 Dec; 26(6):360-3. PubMed ID: 10374328
[TBL] [Abstract][Full Text] [Related]
38. Comparison of K-ras point mutations at codon 12 and p21 expression in pancreatic cancer between Japanese and Chinese patients.
Song MM; Nio Y; Dong M; Tamura K; Furuse K; Tian YL; He SG; Shen K
J Surg Oncol; 2000 Nov; 75(3):176-85. PubMed ID: 11088049
[TBL] [Abstract][Full Text] [Related]
39. Altered expression of nm23-H1 and c-erbB-2 proteins have prognostic significance in adenocarcinoma but not in squamous cell carcinoma of the uterine cervix.
Mandai M; Konishi I; Koshiyama M; Komatsu T; Yamamoto S; Nanbu K; Mori T; Fukumoto M
Cancer; 1995 May; 75(10):2523-9. PubMed ID: 7736397
[TBL] [Abstract][Full Text] [Related]
40. P21 protein expression and ras-oncogene mutations in gastric carcinoma: correlation with clinical data.
Kasper HU; Schneider-Stock R; Mellin W; Roessner A
Int J Oncol; 1998 Jan; 12(1):69-74. PubMed ID: 9454888
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]